Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Reports Record Full Year 2009 Preliminary Unaudited Results
2009 Highlights: , Feb 16, 2010 (GlobeNewswire via COMTEX News Network) -- Record revenue of EUR 24.9 million (USD 34.7 million), up 7.9% year-over-year -- Ablatherm-HIFU RPP treatments increased 24.0% year-over-year -- Strong EUR 12.7 million (USD 18.2 million) cash position LYON, France, Feb.
View HTML
Toggle Summary EDAP Reports on FDA Meeting
LYON, France, Feb 2, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that the FDA at its meeting on January 28, 2010 confirmed the recommendations of the Gastroenterology and Urology Devices Panel of the Medical
View HTML
Toggle Summary EDAP Continues FDA Discussion on U.S. ENLIGHT Trial Protocol
LYON, France, Jan 25, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that a meeting with the U.S. Food and Drug Administration (FDA) has been scheduled for later this month.
View HTML
Toggle Summary EDAP Appoints U.S. Vice President of Sales and Marketing
Enhances Strategy to Drive U.S. Sonolith I-Sys Device Sales
View HTML
Toggle Summary EDAP Continues to Expand Ablatherm-HIFU Installed Base
Dec 17, 2009 (GlobeNewswire via COMTEX News Network) -- Secures Two Ablatherm-HIFU Device Sales in Europe Finalizing Additional Sales LYON, France, Dec. 17, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that two major hospitals in
View HTML
Toggle Summary EDAP Reports on FDA Panel Meeting
LYON, France, Dec 16, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that the Company attended the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee Meeting of the U.S.
View HTML
Toggle Summary EDAP Reports Third Quarter 2009 Financial Results
Highlights: , Nov 17, 2009 (GlobeNewswire via COMTEX News Network) -- Total revenues increased 19.8% for the first nine months of 2009 -- Ablatherm- HIFU revenue per procedure (RPP) treatments increased 36.7% for the first nine months of 2009 -- Sonolith I-Sys Lithotripter received U.S.
View HTML
Toggle Summary EDAP Appoints Top U.S. Urologist to Lead FDA HIFU Clinical Trial
LYON, France, Nov 16, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Dr. Inderbir S. Gill, professor and chairman of the Department of Urology at the Keck School of Medicine of the University of Southern
View HTML
Toggle Summary EDAP Announces Webcast and Conference Call of Third Quarter 2009 Results
LYON, France, Nov 4, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2009 earnings announcement, which will take place on Tuesday, November 17, 2009, before the opening of
View HTML
Toggle Summary EDAP Secures First U.S. Sonolith I-Sys Device Sale
Follows Recent FDA 510K Approval
View HTML